BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20458626)

  • 1. Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-naïve patients with chronic hepatitis C.
    Rawlins SR; El-Zammar O; Zinkievich JM; Newman N; Levine RA
    Dig Dis Sci; 2010 Jul; 55(7):2049-57. PubMed ID: 20458626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.
    Jazwinski AB; Thompson AJ; Clark PJ; Naggie S; Tillmann HL; Patel K
    J Viral Hepat; 2012 Apr; 19(4):278-82. PubMed ID: 22404726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection.
    Ahmed AM; Hassan MS; Abd-Elsayed A; Hassan H; Hasanain AF; Helmy A
    Saudi J Gastroenterol; 2011; 17(4):245-51. PubMed ID: 21727730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis.
    Gordon A; McLean CA; Pedersen JS; Bailey MJ; Roberts SK
    J Hepatol; 2005 Jul; 43(1):38-44. PubMed ID: 15876468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Bugianesi E; Bouserhal T; Marini F; Ridolfi F; Tarsetti F; Ancarani F; Petrelli E; Peruzzi E; Lo Cascio M; Rizzetto M; Marchesini G; Benedetti A
    Gut; 2007 Sep; 56(9):1296-301. PubMed ID: 17392334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of fibrosis and steatosis in liver biopsies from patients with chronic hepatitis C.
    Zaitoun AM; Al Mardini H; Awad S; Ukabam S; Makadisi S; Record CO
    J Clin Pathol; 2001 Jun; 54(6):461-5. PubMed ID: 11376020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
    Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
    Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
    Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
    Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An inexpensive and worldwide available digital image analysis technique for histological fibrosis quantification in chronic hepatitis C.
    Campos CF; Paiva DD; Perazzo H; Moreira PS; Areco LF; Terra C; Perez R; Figueiredo FA
    J Viral Hepat; 2014 Mar; 21(3):216-22. PubMed ID: 24438683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum apoptosis markers related to liver damage in chronic hepatitis C: sFas as a marker of advanced fibrosis in children and adults while M30 of severe steatosis only in children.
    Valva P; Casciato P; Lezama C; Galoppo M; Gadano A; Galdame O; Galoppo MC; Mullen E; De Matteo E; Preciado MV
    PLoS One; 2013; 8(1):e53519. PubMed ID: 23326448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C.
    Macaluso FS; Maida M; Cammà C; Cabibbo G; Cabibi D; Alduino R; Di Marco V; Craxì A; Petta S
    J Hepatol; 2014 Sep; 61(3):523-9. PubMed ID: 24815874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in digital quantification technique enhance discrimination between mild and advanced liver fibrosis in chronic hepatitis C.
    Lazzarini AL; Levine RA; Ploutz-Snyder RJ; Sanderson SO
    Liver Int; 2005 Dec; 25(6):1142-9. PubMed ID: 16343064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C.
    Sasso M; Tengher-Barna I; Ziol M; Miette V; Fournier C; Sandrin L; Poupon R; Cardoso AC; Marcellin P; Douvin C; de Ledinghen V; Trinchet JC; Beaugrand M
    J Viral Hepat; 2012 Apr; 19(4):244-53. PubMed ID: 22404722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.